ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 256 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q4 2020. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,010,000 | +98.4% | 24,383 | +247.6% | 0.06% | +121.4% |
| Q1 2022 | $509,000 | +83.8% | 7,015 | +113.2% | 0.03% | +180.0% |
| Q4 2021 | $277,000 | -52.4% | 3,290 | -49.0% | 0.01% | -66.7% |
| Q3 2021 | $582,000 | -52.3% | 6,448 | -49.6% | 0.03% | -42.3% |
| Q2 2021 | $1,221,000 | +127.0% | 12,801 | +95.7% | 0.05% | -10.3% |
| Q3 2020 | $538,000 | +151.4% | 6,542 | +138.6% | 0.06% | +61.1% |
| Q2 2020 | $214,000 | -34.2% | 2,742 | -62.5% | 0.04% | -7.7% |
| Q1 2020 | $325,000 | +18.6% | 7,316 | +69.7% | 0.04% | +62.5% |
| Q2 2019 | $274,000 | – | 4,311 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| First Light Asset Management, LLC | 437,512 | $31,772,000 | 2.80% |
| RTW INVESTMENTS, LP | 1,373,284 | $99,728,000 | 2.06% |
| Rock Springs Capital Management LP | 1,028,109 | $74,661,000 | 1.88% |
| Privium Fund Management B.V. | 112,727 | $8,186,000 | 1.81% |
| Avidity Partners Management LP | 869,000 | $63,107,000 | 1.31% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 525,100 | $38,133,000 | 1.16% |
| Boxer Capital, LLC | 200,000 | $14,524,000 | 0.75% |
| SECTOR GAMMA AS | 46,221 | $3,357,000 | 0.73% |
| FEDERATED HERMES, INC. | 3,987,728 | $289,589,000 | 0.65% |
| EMERALD ADVISERS, LLC | 223,952 | $16,263,000 | 0.62% |